Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

NCT05865028 is registered in ClinicalTrials.gov with Elizabeth J Franzmann as lead sponsor.

NCT NCT05865028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05865028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia
Lead sponsor
Elizabeth J Franzmann
Phase
Phase 2
Overall status
Recruiting
Start date
May 24, 2023
Completion date
May 24, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral carcinoma in situ, oral cavity dysplasia, oropharyngeal dysplasia